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Abstract Although Gas6 is identified as a growth factor for
vascular smooth muscle cells (VSMCs), its roles in these cells
have not been clearly elucidated. To examine the role of Gas6 in
atherosclerosis, we examined the effects of Gas6 on scavenger
receptor family expression in VSMCs. Scavenger receptor class
A, one of the scavenger receptor family members, was
upregulated in VSMCs by Gas6. Furthermore, the atherogenic
lipoprotein, oxidized LDL, induced Gas6 production in these
cells. These results indicate that Gas6 plays an important role in
foam cell formation in human VSMCs.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Gas6, the product of growth arrest-speci¢c gene 6, poten-
tiates the proliferation and prevents the cell death of vascular
smooth muscle cells (VSMCs) [1,2]. Gas6 was originally
cloned as one of the growth arrest-speci¢c genes isolated by
subtractive hybridization on the basis of preferential expres-
sion in the G0 phase of the cell cycle [3]. It has been demon-
strated that Gas6 is a ligand of receptor tyrosine kinases, Axl
[4]. Recent reports indicated that Gas6 promotes Axl-medi-
ated adhesion, suggesting adhesion as one function for the
Gas6-Axl interaction [5], and Gas6 can act as a chemoattrac-
tant for migration in both rat and human primary VSMCs [6].
However, Gas6’s biological activity is still poorly understood.
During atherogenesis, VSMCs migrate from the media to
the intima of the arterial wall, where they proliferate and
accumulate lipid, becoming foam cells. Although the factors
contributing to the regulation of smooth muscle cell scavenger
receptor activity in vivo are unknown, several cytokines are
reported to regulate the activity of scavenger receptor in
VSMCs [7,8]. Thus, these cytokines are presumed to play
important roles in the phenotypic change of VSMCs acting
in an autocrine or paracrine manner [9].
It has been proposed that modi¢ed LDL is the atherogenic
ligand for scavenger receptor on macrophages and smooth
muscle cells that causes the massive accumulation of lipid
and foam cell formation [10]. The uptake of oxidized low
density lipoprotein (OxLDL) by macrophages is a key event
implicated in the initiation and development of atherosclerotic
lesions. Several macrophage surface receptors, CD36 (a class
B scavenger receptor) [11], CD68 [12] and the macrophage
scavenger receptor (a class A scavenger receptor; SRA) [13],
have been identi¢ed as the major receptors that bind and
internalize OxLDL. Scavenger receptor is detected in VSMCs
in the intima but not in normal VSMCs, demonstrating that
smooth muscle cell scavenger receptor activity is upregulated
in atherosclerotic lesions [7,8].
In this study, the regulation of scavenger receptor expres-
sion in VSMCs was investigated using an established human
vascular smooth muscle cell line.
2. Materials and methods
2.1. Materials
Interferon-Q (IFN-Q) and interleukin-1L (IL-1L) were obtained from
Research Biochemicals International (Natick, MA, USA). Phorbol
12-myristate 13-acetate (PMA) was purchased from Sigma (St. Louis,
MO, USA). OxLDL was prepared as described previously [12]. All
other reagents were of analytical grade.
2.2. Cell culture
A human vascular smooth muscle cell line, ISS10, was established
as described previously [14]. ISS10 cells were plated in DMEM me-
dium (Gibco BRL, Osaka, Japan) supplemented with 10% fetal calf
serum, 100 Wg/ml streptomycin and 100 U/ml penicillin in a humidi-
¢ed atmosphere containing 5% CO2.
2.3. Preparation of recombinant human Gas6 and anti-human Gas6
antibody
CHO cells were transfected with human Gas6 expression plasmid.
Con£uent cells were cultured in protein-free culture medium, PM-
1000 (Eiken, Tokyo, Japan), in the presence of 4 WM vitamin K2.
Recombinant human Gas6 was puri¢ed from the culture medium as
described elsewhere [1]. Rabbits were immunized with recombinant
human Gas6. Anti-human Gas6 IgG was puri¢ed using the Ampure
PA kit (Amersham, Arlington Heights, IL, USA).
2.4. RNA isolation and RT-PCR analysis
Total RNA was isolated from ISS10 cells by single-step acid gua-
nidinium thiocyanate-phenol-chloroform extraction [18]. Axl and
SRA expression was determined by PCR analysis of the reverse tran-
scribed RNA as described previously [15]. A primer pair was designed
as matching the published sequence of Axl [16] (sense: 5P-GG-
TGGCTGTGAAGACGATGA-3P and antisense: 5P-CTCAGATA-
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CTCCATGCCACT-3P) and SR-A [13]; (5P common type I and type
II sense primer: 5P-GGGAACATTCTCAGACCTTGAG-3P, 3P type
I-speci¢c antisense primer: 5P-TGTCCATAGTGAGCTGCCTTGT-
3P, and 3P type II-speci¢c primer: 5P-TGCCCTAATATGATCAGT-
GAGTTG-3P). As a control, L-actin was ampli¢ed and analyzed
under identical conditions using an appropriate set of primers.
2.5. Proliferation assay
ISS10 cells (105) were cultured in 96-well plates in 200 Wl of DMEM
complete medium. Four hours before harvesting, cells were pulsed
with 1 WCi/well [3H]TdR (speci¢c activity = 6.7Ci/mmol, DuPont
Company, Wilmington, DE, USA) and then harvested onto glass ¢ber
¢lters using an automated cell harvester and counted in a Packard
liquid scintillation counter (Hewlett-Packard Co., Palo Alto, CA,
USA). The data are presented as the mean cpm of triplicate cultures
þ S.E.M.
2.6. Western blot analysis
ISS10 cells were washed and scraped in phosphate-bu¡ered saline
(PBS) and lysed as described previously [17]. The proteins were frac-
tionated by size on 7.5% SDS-polyacrylamide gels, and transferred to
polyvinylidene di£uoride membranes for immunoblotting. The mem-
branes were incubated with 0.1% Tween 20 in PBS (PBS-T) contain-
ing anti-SRA antibody (diluted 1/3000 from whole antiserum), anti-
cyclophilin A, or anti-Gas6 antibody. The membranes were then
washed with PBS-T, and incubated for 1 h at room temperature in
PBS-T containing horseradish peroxidase-linked second antibodies.
The antibody binding was visualized by chemiluminescence detection
(ECL, Amersham Corp., Arlington Heights, IL, USA).
2.7. Uptake of AcLDL in ISS10 cells
1,1P-Dioctadecyl-1-13,3,3P3P-tetramethyl-indo-carbocyanine perchlo-
rate-labeled acetyl-LDL (DiI-AcLDL; Biomedical Technologies Inc.,
Stoughton, MA, USA) was added to the culture medium at a ¢nal
concentration of 10 Wg/ml. The cells were incubated for 4 h at 37‡C,
washed with PBS, and then ¢xed and analyzed using a £uorescence
microscope.
2.8. Statistical analysis
Statistical comparisons were made by one-way analysis of variance
and Student’s t-test, with P6 0.05 considered signi¢cant.
3. Results
3.1. Gene expression of the receptor for Gas6 and e¡ects of
Gas6 on smooth muscle cell line growth
Gas6 is a common ligand for Axl, one of the members of
the Axl/Sky receptor family [4]. To examine Axl gene expres-
sion in a vascular smooth muscle cell line, we employed the
reverse-transcribed PCR analysis with mRNA from ISS10
cells. Although a previous study reported that Axl was upre-
gulated in a human leukemia cell line, K562 treated with
PMA [16], Axl mRNA was detected in ISS10 cells at the
same level found in K562 treated with PMA (Fig. 1A).
When ISS10 cells were stimulated for 24 h in the presence
of Gas6 at given concentrations, their proliferative response
to Gas6 was increased in a dose-dependent manner (Fig. 1B).
3.2. E¡ects of Gas6 on scavenger receptor expression in human
smooth muscle cells
We analyzed the e¡ects of Gas6 on scavenger receptor ex-
pression in ISS10 cells with a speci¢c antibody against human
SRA. Fig. 2A shows that Gas6 stimulated SRA expression in
ISS10. Positive controls (IFN-Q) also increased SR-A expres-
sion in ISS10 (Fig. 2). To determine whether enhanced SRA
expression by Gas6 depends on increased levels of SRA
mRNA, RT-PCR analyses were performed. ISS10 cells were
incubated with 10 ng/ml of Gas6 for 24 h, and total RNA was
extracted and subjected to RT-PCR analyses. As shown in
Fig. 2B, Gas6 treatment at 10 ng/ml for 24 h increased the
SRA mRNA level. In contrast, Gas6 had no e¡ect on the
expression of other scavenger receptors including CD36 and
CD68 in ISS10 cells (data not shown).
3.3. E¡ects of Gas6 on uptake of AcLDL
To determine whether the upregulated expression of SRA
by Gas6 is correlated with an enhanced uptake of AcLDL,
amounts of DiI-AcLDL internalized into ISS10 were meas-
ured. After treatment with Gas6 for 24 h, con£uent mono-
layers of ISS10 were incubated with DiI-AcLDL. Fluores-
cence microscopy was carried out to evaluate the cellular
uptake of DiI-AcLDL. In Gas6-treated ISS10, signi¢cant
amounts of DiI-labeled AcLDL were internalized (Fig. 3).
Fig. 1. A: Axl gene expression in ISS10 cells. Total RNA was iso-
lated from ISS10 cells and K562 treated with PMA, then RT-PCR
was performed as described in Section 2. L-Actin was ampli¢ed as
an internal control. Lane 1, DNA size marker (xX174); lane 2,
ISS10 cells; lane 3, K562 treated with PMA. An identical experi-
ment independently performed gave similar results. B: Gas6-induced
DNA synthesis in ISS10 cells. In 24-well plates, con£uent ISS10
cells were rendered quiescent after incubation in DMEM for 24 h.
ISS10 cells were stimulated with the indicated amount of Gas6 for
24 h, and then the cells were pulsed with [3H]thymidine for 4 h.
The data are presented as the mean cpm of triplicate cultures þ
S.E.M.
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These results demonstrate that increased SRA expression by
Gas6 was associated with enhanced AcLDL uptake in ISS10.
3.4. OxLDL induced Gas6 expression
A previous report indicated that human VSMCs express
Gas6 [1], and we have con¢rmed that ISS10 also expressed
Gas6 by Western blot analysis. It was recently reported that
modi¢ed LDL enhances SRA expression [18]. To examine the
e¡ects of the modi¢ed form of LDL on Gas6 expression in
ISS10 cells, we incubated ISS10 cells with various concentra-
tions of OxLDL. As shown in Fig. 4A, OxLDL stimulated
Gas6 expression in a dose-dependent manner in ISS10 cells. In
contrast, cyclophilin A expression was not a¡ected by OxLDL
treatment in ISS10 cells. Gas6 was maximally induced by
OxLDL after 12 h incubation with OxLDL. On the other
hand, OxLDL induced SRA expression in ISS10 cells after
24 h incubation (Fig. 4B).
4. Discussion
In the current study, we have demonstrated an increased
expression of SRA, a receptor for OxLDL, in a human
smooth muscle cell line after Gas6 treatment. We also re-
vealed that the increase in type I and II scavenger receptor
mRNA expression is correlated with an increase in scavenger
receptor activity in human smooth muscle cells by Gas6 treat-
ment. Furthermore, we have shown that the expression of
Gas6 was increased in the presence of OxLDL in ISS10.
Our results suggest important interactions between Gas6-Axl
and SRA, which is the receptor for OxLDL. Thus, the future
characterization of Gas6-Axl signaling should yield important
discoveries regarding the mechanisms underlying the foam cell
formation of human VSMCs.
Whereas the scavenger receptor activity in di¡erentiated
macrophages can be regulated in a narrow range by various
growth factors and cytokines, that in VSMCs is regulated
over a wide range [9]. The regulation of scavenger receptor
activity in VSMCs and macrophages, however, is fundamen-
tally di¡erent. In macrophages, scavenger receptor expression
is stimulated constitutively, and there is a high level of recep-
tor activity. In smooth muscle cells, scavenger receptor expres-
sion is weak in the absence of stimulation [7,8].
Li et al. [8] demonstrated that after balloon injury, the
aorta smooth muscle cells in the neointima of hypercholester-
olemic rabbits express scavenger receptors, whereas smooth
muscle cells in the media do not. These results clearly dem-
onstrate that scavenger receptor expression is upregulated in
smooth muscle cells in atherosclerotic lesions. The factors
leading to scavenger receptor regulation in VSMCs in vivo
are unknown. However, Melaragno et al. reported that the
expression of Axl is increased in neointima VSMCs of rat
carotid arteries after balloon injury and that Axl expression
is selectively regulated by G protein-coupled receptor agonists
in vitro [19]. Wu et al. [20] have shown that scavenger recep-
tor expression in human monocyte-derived macrophages is
regulated via a signal transduction pathway involving ras,
AP1 (c-jun and junB), and ets domain proteins. In the present
Fig. 2. E¡ect of Gas6 on SRA expression in ISS10 cells. A: West-
ern blot analysis. Total cell protein extracted with 1% NP40 from
untreated ISS10 cells (lanes 1 and 2) and ISS10 cells treated for 24 h
with IL-1L, IFN-Q, or Gas6 was separated by SDS-PAGE, trans-
ferred to a nitrocellulose membrane and blotted with anti-SRA anti-
body. Each lane contained 10 Wg of protein. Lane 1, control; lane
2, IL-1L ; lane 3; INF-Q ; lane 4, Gas6. An identical experiment in-
dependently performed gave similar results. B: RT-PCR analysis of
SRA mRNA expression. Total RNA was isolated from ISS10 cells
with or without Gas6 and RT-PCR was performed as described in
Section 2. L-Actin was ampli¢ed as an internal control. Lane M,
DNA size marker (xX174); lane 1, Gas6-treated ISS10; lane 2, un-
treated ISS10. An identical experiment independently performed
gave similar results.
Fig. 3. E¡ect of Gas6 on uptake of DiI-AcLDL in ISS10 cells. On
day 1, ISS10 cells were plated in complete medium. On day 2, the
monolayers were incubated without (A) or with 10 ng/ml Gas6 (B)
for 24 h at 37‡C. On day 3, the subcon£uent cells were re-fed with
the medium containing DiI-AcLDL (1 Wg of protein/ml) and incu-
bated for 4 h at 37‡C. The cells were photographed with a £uores-
cence microscope with a rhodamine ¢lter package. An identical ex-
periment independently performed gave similar results.
FEBS 22729 5-10-99
K. Murao et al./FEBS Letters 459 (1999) 363^366 365
study, we showed that Gas6 stimulated the expression of scav-
enger receptor in an Axl-expressing human smooth muscle cell
line. Thus, Gas6 may play an important role in foam cell
formation in atherosclerotic lesions.
Many studies also demonstrated that VSMCs express type I
and II scavenger receptors that bind, internalize, and degrade
modi¢ed LDL, suggesting that the scavenger receptor-medi-
ated uptake of modi¢ed LDL by VSMCs also leads to lipid
accumulation and foam cell formation in vivo as proposed in
macrophages [7^9]. Growth factors secreted by cells in devel-
oping atherosclerotic lesions could stimulate scavenger recep-
tor activity in VSMCs and contribute to lipid accumulation
and foam cell formation [7]. OxLDL, one of the atherogenic
lipoproteins, induces the expression of several genes including
scavenger receptors [21]. The present study indicated that
Gas6 induced SRA expression and the time-course study
(Fig. 4B) showed that OxLDL stimulated Gas6 expression
before the induction of SRA expression. Taken together, the
results suggest that Gas6 induced by OxLDL stimulated SRA
expression to take up OxLDL. Further investigation is needed
to test this hypothesis.
These results, showing Gas6 upregulation of scavenger re-
ceptor expression in a human smooth muscle cell line, suggest
that Gas6 may play an important role in foam cell formation
in the progress of atherosclerosis.
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Fig. 4. E¡ect of OxLDL on Gas6 expression in ISS10 cells. ISS10
cell monolayers were exposed to OxLDL at di¡erent concentrations
or for di¡erent periods of time and cell lysates were analyzed by
SDS-PAGE and Western blotting with anti Gas6, anti-SRA or anti-
cyclophilin A antibody. A: Dose response of OxLDL on Gas6 ex-
pression. Cyclophilin A was used as an internal control. Lane 1,
control; lane 2, OxLDL 5 Wg/ml; lane 3, OxLDL 10 Wg/ml; lane 4,
OxLDL 20 Wg/ml; lane 5, OxLDL 50 Wg/ml. B: Western blot analy-
sis was performed to determine the time course of SRA and Gas6
expression in ISS10 cells after 50 Wg/ml OxLDL treatment. An iden-
tical experiment independently performed gave similar results.
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